SCHEMBL2053940

SCHEMBL2053940

CCCCCc1cc2cc(Br)ccc2cc1N(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 4/20 0.36
OXER1 Q8TDS5 2/20 0.36
LMNA P02545 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP2A6 P11509 1/20 0.35
NCEH1 Q6PIU2 1/20 0.35
MAPT P10636 3/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
ALOX5 P09917 1/20 0.34
TYR P14679 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
SLC6A4 P31645 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2050433 0.80 NCEH1 (0.41) LMNAL3MBTL1CYP2A6NCEH1MAPT
SCHEMBL31498466 0.74 BDKRB2 (0.46) TLR8LMNACYP2A6TP53CYP3A4
SCHEMBL4586831 0.73 ESR1 (0.44) TLR8LMNATP53CYP3A4SLC6A4
SCHEMBL2400221 0.72 ESR1 (0.47) TLR8LMNATP53CYP3A4SLC6A4
SCHEMBL2403161 0.72 ESR1 (0.47) TLR8LMNATP53CYP3A4SLC6A4
SCHEMBL9128028 0.72 ESR1 (0.47) TLR8LMNATP53CYP3A4SLC6A4
SCHEMBL27878175 0.70 TYR (0.50) LMNAMAPTMEN1KMT2ATP53
SCHEMBL27827947 0.70 TYR (0.50) LMNAMAPTMEN1KMT2ATP53
SCHEMBL5011027 0.69 ESR1 (0.40) TLR8LMNATP53CYP3A4SLC6A4
SCHEMBL29724725 0.69 TLR8 (0.67) TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2331552-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2011-06-15 EP disclosed
WO-2010036551-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-04-01 WO disclosed